Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers : vimarsana.com

Three early-phase clinical studies presented by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2024 show promising initial data for patients with lymphoma, gastric or gastroesophageal junction cancers, and specific molecularly selected tumors.

Related Keywords

United States , Texas , American , Klus Pharma , Jordi Rodon , Timothy Yap , Merck Co , Development Agreement , Andrew Sabin Family Fellowship Program , American Association For Cancer Research , University Of Texas Md Anderson Cancer Center , Experimental Therapeutics Clinical Trials Network , Bristol Myers Squibb Company , National Cancer Institute Therapy Evaluation Program , National Cancer Institute , Astrazeneca Pharmaceuticals , National Institutes Of Health , Anderson Cancer , Cancer Center , American Association , Cancer Research , Annual Meeting , Paolo Strati , Lymphoma Society Scholar , Clinical Research Award , Kite Scholar Award , Andrew Sabin Family Fellowship , Investigational Cancer Therapeutics , Therapeutics Discovery , National Institutes , Therapeutics Clinical Trials Network , Cooperative Research , Cancer , Nemia , Ntibody , Ntibody Drug Conjugate , Lood , Ell , Linical Trial , Fficacy , Odgkin Lymphoma , Ymphoma , Utation , Yeloma , Eutropenia , On Hodgkin Lymphoma , H , Esearch , Ituximab , Herapeutics ,